Transparency
We believe in providing an open environment to help build a foundation of trust and respect among our colleagues, healthcare professionals, patients, stockholders, and the public. Making information available is important as we continue to operate our business to the highest standards, and in keeping with current laws and regulations.
We are firmly focused on Our Mission and take our responsibility for transparency seriously. Sustainability reporting is a clear example of an area in which we will continue to work to increase transparency as we show progress towards our Sustainability 2020 Goals.
At Bristol Myers Squibb we work in partnership with lots of organisations to meet the needs of patients and the NHS. Bristol Myers Squibb is committed to working in partnership with others in a way which is fully compliant with the Association of the British Pharmaceutical Industry (ABPI) Code of Practice. Our objective is to act transparently with all stakeholders and the community at large.
Quick Links
UK Transparency
Bristol Myers Squibb is widely recognised for excellence in providing some of the world’s most important medicines for patients. At the same time, we strive to be transparent by providing information about treatments we are studying, whether they are investigational compounds, or new indications for existing marketed products.
At Bristol Myers Squibb we work in partnership with lots of organisations to meet the needs of patients and the NHS. Bristol Myers Squibb is committed to working in partnership with others in a way which is fully compliant with the Association of the British Pharmaceutical Industry (ABPI) Code of Practice. Our objective is to act transparently with all stakeholders and the community at large.
Methodologies on What We Are Disclosing
For BMS Methodology document please see the Disclosure UK database hosted on the website of the ABPI
Disclosure Reports
Patient Organisations
To view the latest information on payments Bristol Myers Squibb has made to support the work of patient organisations, please click here. Information on payments made in 2022 are available here and 2021 available here. For information on EFPIA - Patient Advocacy Group Methodology please click here.
Members of the Public
To view the latest information on payments Bristol Myers Squibb has made when working with Members of the Public (including patients and journalists), please click here. Information on payments made in 2022 are available here.
Health Professionals and Healthcare Organisations
For transparency reports covering the latest three years of reportable data for Health Professional and Healthcare Organisations, see the Disclosure UK database hosted on the website of the ABPI.
For information on our methodological approach for HCPs, HCOs and Members of the Public (including patients and journalists), please click here.
If you have a question about Transfers of Value reported by Bristol Myers Squibb, contact us via transparency_EU@bms.com
NO-GB-2400156
June 2024